Literature DB >> 16797480

Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells.

Mary A Selak1, Raul V Durán, Eyal Gottlieb.   

Abstract

HIFalpha prolyl hydroxylases (PHDs) are a family of enzymes that regulate protein levels of the alpha subunit of the hypoxia inducible transcription factor (HIF) under different oxygen levels. PHDs catalyse the conversion of a prolyl residue, molecular oxygen and alpha-ketoglutarate to hydroxy-prolyl, carbon dioxide and succinate in a reaction dependent on ferrous iron and ascorbate as cofactors. Recently it was shown that pseudo-hypoxia, HIF induction under normoxic conditions, is an important feature of tumours generated as a consequence of inactivation of the mitochondrial tumour suppressor 'succinate dehydrogenase' (SDH). Two models have been proposed to describe the link between SDH inhibition and HIF activation. Both models suggest that a mitochondrial-generated signal leads to the inhibition of PHDs in the cytosol, however, the models differ in the nature of the proposed messenger. The first model postulates that mitochondrial-generated hydrogen peroxide mediates signal transduction while the second model implicates succinate as the molecular messenger which leaves the mitochondrion and inhibits PHDs in the cytosol. Here we show that pseudo-hypoxia can be observed in SDH-suppressed cells in the absence of oxidative stress and in the presence of effective antioxidant treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797480     DOI: 10.1016/j.bbabio.2006.05.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  The redox basis of epigenetic modifications: from mechanisms to functional consequences.

Authors:  Anthony R Cyr; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2011-02-05       Impact factor: 8.401

2.  SDHA is a tumor suppressor gene causing paraganglioma.

Authors:  Nelly Burnichon; Jean-Jacques Brière; Rossella Libé; Laure Vescovo; Julie Rivière; Frédérique Tissier; Elodie Jouanno; Xavier Jeunemaitre; Paule Bénit; Alexander Tzagoloff; Pierre Rustin; Jérôme Bertherat; Judith Favier; Anne-Paule Gimenez-Roqueplo
Journal:  Hum Mol Genet       Date:  2010-05-18       Impact factor: 6.150

Review 3.  Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.

Authors:  Patricia L M Dahia
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

Review 4.  Oncometabolites in renal cancer.

Authors:  Cissy Yong; Grant D Stewart; Christian Frezza
Journal:  Nat Rev Nephrol       Date:  2019-10-21       Impact factor: 28.314

5.  Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells.

Authors:  Elaine D MacKenzie; Mary A Selak; Daniel A Tennant; Lloyd J Payne; Stuart Crosby; Casper M Frederiksen; David G Watson; Eyal Gottlieb
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

Review 6.  Mitochondria and cancer.

Authors:  Douglas C Wallace
Journal:  Nat Rev Cancer       Date:  2012-10       Impact factor: 60.716

7.  Three autocrine feedback loops determine HIF1 alpha expression in chronic hypoxia.

Authors:  Amina A Qutub; Aleksander S Popel
Journal:  Biochim Biophys Acta       Date:  2007-07-20

8.  Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis.

Authors:  Robert D Guzy; Bhumika Sharma; Eric Bell; Navdeep S Chandel; Paul T Schumacker
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

9.  Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia.

Authors:  Amina A Qutub; Aleksander S Popel
Journal:  Mol Cell Biol       Date:  2008-06-16       Impact factor: 4.272

10.  Transcriptional Regulation of SDHa flavoprotein by nuclear respiratory factor-1 prevents pseudo-hypoxia in aerobic cardiac cells.

Authors:  Claude A Piantadosi; Hagir B Suliman
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.